Mironid
Latest round
- Series B
Last raised
- Mar 2026
Total raised
- $58M
Investors
- 8
About Mironid
Mironid Ltd. is a UK-based biotechnology company specializing in the development of innovative therapeutic solutions targeting rare diseases through its advanced research and discovery programs. The University of Strathclyde recognizes Mironid as a university spinout and explicitly identifies Pyne as a co-founder. In August 2026, Mironid Ltd. Mironid Ltd. specializes in delivering advanced therapeutic solutions aimed at treating rare diseases. Its primary offerings include cutting-edge investigational medicines developed through rigorous research and scientific collaboration. The company’s products are designed to address unmet medical needs, particularly for conditions that lack effective treatments. These solutions are aimed at healthcare providers and patients predominantly in Europe and North America, ensuring compliance with regional regulations and standards. In the most recent year, 2024, Mironid Ltd.40. The company’s revenue model is based on securing investment for its research and development programs rather than generating direct sales at this stage. Mironid intends to evaluate the candidate’s safety and efficacy, progress its PDE-targeted therapeutic pipeline and move assets toward value-inflection points. Its broader ambition is to establish a leadership position in phosphodiesterase-based therapies for rare diseases with substantial unmet clinical need.
Who invested in Mironid
8 investors across 3 rounds
See all investors in Mironid
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mironid
Who invested in Mironid?
Mironid has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mironid raised?
Mironid has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Mironid last raise money?
Mironid's most recent round on record is a Series B, in Mar 2026.
What does Mironid do?
Mironid is a pharmaceuticals company.
Where is Mironid headquartered?
Mironid is headquartered in Glasgow, UK.
Which VCs invest in companies like Mironid?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Mironid's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Mironid? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.